Imaging brain inflammation in epilepsy

Neuroscience

Volumn 279, Issue , 2014, Pages 238-252

  Amhaoul, H ^a   Staelens, S ^a   Dedeurwaerdere, S ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Epilepsy; MRI; Neuroinflammation; Non invasive imaging; PET

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CANNABINOID 2 RECEPTOR; GLUTATHIONE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; METHIONINE; NITRIC OXIDE; TRANSCRIPTION FACTOR; TRYPTOPHAN; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLOOD BRAIN BARRIER; CELL ACTIVATION; CELL INFILTRATION; DISEASE ASSOCIATION; EPILEPSY; EPILEPTOGENESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MACROGLIA; MICROGLIA; MOLECULAR IMAGING; MOLECULAR MECHANICS; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RISK ASSESSMENT; TRYPTOPHAN METABOLISM; ANIMAL; ENCEPHALITIS; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; ENCEPHALITIS; EPILEPSY; HUMANS; MOLECULAR IMAGING; NEUROIMAGING;

EID: 84907545937     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.08.044     Document Type: Review

References (174)

1. Akhtari M., Bragin A., Cohen M., Moats R., Brenker F., Lynch M.D., Vinters H.V., Engel J. Functionalized magnetonanoparticles for MRI diagnosis and localization in epilepsy. Epilepsia 2008, 49:1419-1430.
2. Akin D., Ravizza T., Maroso M., Carcak N., Eryigit T., Vanzulli I., Aker R.G., Vezzani A., Onat F.Y. IL-1beta is induced in reactive astrocytes in the somatosensory cortex of rats with genetic absence epilepsy at the onset of spike-and-wave discharges, and contributes to their occurrence. Neurobiol Dis 2011, 44:259-269.
3. Akopov S.E., Simonian N.A., Grigorian G.S. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke 1996, 27:1739-1743.
4. Ashton J.C., Wright J.L., McPartland J.M., Tyndall J.D. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. Curr Med Chem 2008, 15:1428-1443.
5. Ballinger J.R., Gnanasegaran G. Radiolabelled leukocytes for imaging inflammation: how radiochemistry affects clinical use. Q J Nucl Med Mol Imaging 2005, 49:308-318.
6. Balosso S., Maroso M., Sanchez-Alavez M., Ravizza T., Frasca A., Bartfai T., Vezzani A. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta. Brain 2008, 131:3256-3265.
7. Banati R.B., Goerres G.W., Myers R., Gunn R.N., Turkheimer F.E., Kreutzberg G.W., Brooks D.J., Jones T., Duncan J.S. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology 1999, 53:2199-2203.
8. Benito C., Nunez E., Tolon R.M., Carrier E.J., Rabano A., Hillard C.J., Romero J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 2003, 23:11136-11141.
9. Benito C., Romero J.P., Tolon R.M., Clemente D., Docagne F., Hillard C.J., Guaza C., Romero J. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 2007, 27:2396-2402.
10. Bergstrom M., Collins V.P., Ehrin E., Ericson K., Eriksson L., Greitz T., Halldin C., von Holst H., Langstrom B., Lilja A., et al. Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine. J Comput Assist Tomogr 1983, 7:1062-1066.
11. Bogdanovic R.M., Syvanen S., Michler C., Russmann V., Eriksson J., Windhorst A.D., Lammertsma A.A., de Lange E.C., Voskuyl R.A., Potschka H. (R)-[C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy model. Neuropharmacology 2014, 85C:104-112.
12. Bouilleret V., Nehlig A., Marescaux C., Namer I.J. Magnetic resonance imaging follow-up of progressive hippocampal changes in a mouse model of mesial temporal lobe epilepsy. Epilepsia 2000, 41:642-650.
13. Brambilla R., Bracchi-Ricard V., Hu W.H., Frydel B., Bramwell A., Karmally S., Green E.J., Bethea J.R. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 2005, 202:145-156.
14. Brand A., Richter-Landsberg C., Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993, 15:289-298.
15. Briellmann R.S., Mark Wellard R., Masterton R.A., Abbott D.F., Berkovic S.F., Jackson G.D. Hippocampal sclerosis: MR prediction of seizure intractability. Epilepsia 2007, 48:315-323.
16. Brodie M.J., Elder A.T., Kwan P. Epilepsy in later life. Lancet Neurol 2009, 8:1019-1030.
17. Brooks-Kayal A.R., Bath K.G., Berg A.T., Galanopoulou A.S., Holmes G.L., Jensen F.E., Kanner A.M., O'Brien T.J., Whittemore V.H., Winawer M.R., Patel M., Scharfman H.E. Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy. Epilepsia 2013, 54(suppl. 4):44-60.
18. Brown G.C., Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 2003, 27:325-355.
19. Buck A., Frey L.D., Blauenstein P., Kramer G., Siegel A., Weber B., Schubiger P.A., Wieser H.G. Monoamine oxidase B single-photon emission tomography with [123I]Ro 43-0463: imaging in volunteers and patients with temporal lobe epilepsy. Eur J Nucl Med 1998, 25:464-470.
20. Bush T.G., Puvanachandra N., Horner C.H., Polito A., Ostenfeld T., Svendsen C.N., Mucke L., Johnson M.H., Sofroniew M.V. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 1999, 23:297-308.
21. Butler T., Ichise M., Teich A.F., Gerard E., Osborne J., French J., Devinsky O., Kuzniecky R., Gilliam F., Pervez F., Provenzano F., Goldsmith S., Vallabhajosula S., Stern E., Silbersweig D. Imaging inflammation in a patient with epilepsy due to focal cortical dysplasia. J Neuroimaging 2013, 23:129-131.
22. Carter S.F., Scholl M., Almkvist O., Wall A., Engler H., Langstrom B., Nordberg A. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med 2012, 53:37-46.
23. Cascino G.D., Jack C.R., Parisi J.E., Sharbrough F.W., Hirschorn K.A., Meyer F.B., Marsh W.R., O'Brien P.C. Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol 1991, 30:31-36.
24. Casellas P., Galiegue S., Basile A.S. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 2002, 40:475-486.
25. Chassidim Y., Veksler R., Lublinsky S., Pell G.S., Friedman A., Shelef I. Quantitative imaging assessment of blood-brain barrier permeability in humans. Fluids Barriers CNS 2013, 10:9.
26. Chauveau F., Van Camp N., Dolle F., Kuhnast B., Hinnen F., Damont A., Boutin H., James M., Kassiou M., Tavitian B. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. J Nucl Med 2009, 50:468-476.
27. Chen M.K., Baidoo K., Verina T., Guilarte T.R. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain 2004, 127:1379-1392.
28. Chugani D.C. Alpha-methyl-l-tryptophan: mechanisms for tracer localization of epileptogenic brain regions. Biomarkers Med 2011, 5:567-575.
29. Chugani D.C., Muzik O. Alpha[C-11]methyl-l-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism. J Cereb Blood Flow Metab 2000, 20:2-9.
30. Chugani H.T., Chugani D.C. Imaging of serotonin mechanisms in epilepsy. Epilepsy Curr 2005, 5:201-206.
31. Chugani H.T., Kumar A., Kupsky W., Asano E., Sood S., Juhasz C. Clinical and histopathologic correlates of 11C-alpha-methyl-l-tryptophan (AMT) PET abnormalities in children with intractable epilepsy. Epilepsia 2011, 52:1692-1698.
32. Chugani H.T., Luat A.F., Kumar A., Govindan R., Pawlik K., Asano E. Alpha-[11C]-Methyl-l-tryptophan-PET in 191 patients with tuberous sclerosis complex. Neurology 2013, 81:674-680.
33. Cosenza-Nashat M., Zhao M.L., Suh H.S., Morgan J., Natividad R., Morgello S., Lee S.C. Expression of the translocator protein of 18kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol 2009, 35:306-328.
34. Danjo S., Ishihara Y., Watanabe M., Nakamura Y., Itoh K. Pentylentetrazole-induced loss of blood-brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthase. Brain Res 2013, 1530:44-53.
35. de Vries E.F., van Waarde A., Buursma A.R., Vaalburg W. Synthesis and in vivo evaluation of 18F-desbromo-DuP-697 as a PET tracer for cyclooxygenase-2 expression. J Nucl Med 2003, 44:1700-1706.
36. de Vries E.F., Vroegh J., Dijkstra G., Moshage H., Elsinga P.H., Jansen P.L., Vaalburg W. Synthesis and evaluation of a fluorine-18 labeled antisense oligonucleotide as a potential PET tracer for iNOS mRNA expression. Nucl Med Biol 2004, 31:605-612.
37. Dedeurwaerdere S., Callaghan P.D., Pham T., Rahardjo G.L., Amhaoul H., Berghofer P., Quinlivan M., Mattner F., Loc'h C., Katsifis A., Gregoire M.C. PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. EJNMMI Res 2012, 2:60.
38. Dedeurwaerdere S., Friedman A., Fabene P.F., Mazarati A., Murashima Y.L., Vezzani A., Baram T.Z. Finding a better drug for epilepsy: antiinflammatory targets. Epilepsia 2012, 53:1113-1118.
39. Dedeurwaerdere S., Jupp B., O'Brien T.J. Positron emission tomography in basic epilepsy research: a view of the epileptic brain. Epilepsia 2007, 48(suppl. 4):56-64.
40. Dedeurwaerdere S., Shultz S.R., Federico P., Engel J. Workshop on neurobiology of epilepsy appraisal: new systemic imaging technologies to study the brain in experimental models of epilepsy. Epilepsia 2014, 55:819-828.
41. Derlon J.M., Bourdet C., Bustany P., Chatel M., Theron J., Darcel F., Syrota A. [11C]l-methionine uptake in gliomas. Neurosurgery 1989, 25:720-728.
42. Devinsky O., Vezzani A., Najjar S., De Lanerolle N.C., Rogawski M.A. Glia and epilepsy: excitability and inflammation. Trends Neurosci 2013, 36:174-184.
43. Dickens A.M., Vainio S., Marjamaki P., Johansson J., Lehtiniemi P., Rokka J., Rinne J., Solin O., Haaparanta-Solin M., Jones P.A., Trigg W., Anthony D.C., Airas L. Detection of microglial activation in an acute model of neuroinflammation Using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180. J Nucl Med 2014, 55:466-472.
44. Dijkhuizen R.M. Advances in MRI-based detection of cerebrovascular changes after experimental traumatic brain injury. Transl Stroke Res 2011, 2:524-532.
45. Doelken M.T., Stefan H., Pauli E., Stadlbauer A., Struffert T., Engelhorn T., Richter G., Ganslandt O., Doerfler A., Hammen T. (1)H-MRS profile in MRI positive- versus MRI negative patients with temporal lobe epilepsy. Seizure 2008, 17:490-497.
46. Dringen R., Kussmaul L., Gutterer J.M., Hirrlinger J., Hamprecht B. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J Neurochem 1999, 72:2523-2530.
47. Duffy B.A., Choy M., Riegler J., Wells J.A., Anthony D.C., Scott R.C., Lythgoe M.F. Imaging seizure-induced inflammation using an antibody targeted iron oxide contrast agent. NeuroImage 2012, 60:1149-1155.
48. Duncan J.S., Sander J.W., Sisodiya S.M., Walker M.C. Adult epilepsy. Lancet 2006, 367:1087-1100.
49. Eddleston M., Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 1993, 54:15-36.
50. Ekblom J., Jossan S.S., Bergstrom M., Oreland L., Walum E., Aquilonius S.M. Monoamine oxidase-B in astrocytes. Glia 1993, 8:122-132.
51. Ekblom J., Jossan S.S., Oreland L., Walum E., Aquilonius S.M. Reactive gliosis and monoamine oxidase B. J Neural Transm Suppl 1994, 41:253-258.
52. Evens N., Vandeputte C., Muccioli G.G., Lambert D.M., Baekelandt V., Verbruggen A.M., Debyser Z., Van Laere K., Bormans G.M. Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging. Bioorgan Med Chem 2011, 19:4499-4505.
53. Evens N., Vandeputte C., Coolen C., Janssen P., Sciot R., Baekelandt V., Verbruggen A.M., Debyser Z., Van Laere K., Bormans G.M. Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer. Nucl Med Biol 2012, 39:389-399.
54. Fabene P.F., Navarro Mora G., Martinello M., Rossi B., Merigo F., Ottoboni L., Bach S., Angiari S., Benati D., Chakir A., Zanetti L., Schio F., Osculati A., Marzola P., Nicolato E., Homeister J.W., Xia L., Lowe J.B., McEver R.P., Osculati F., Sbarbati A., Butcher E.C., Constantin G. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 2008, 14:1377-1383.
55. Filibian M., Frasca A., Maggioni D., Micotti E., Vezzani A., Ravizza T. In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. Epilepsia 2012, 53:1907-1916.
56. Friedman A., Kaufer D., Heinemann U. Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res 2009, 85:142-149.
57. Gilad R., Lampl Y., Eilam A., Boaz M., Loyberboim M. SPECT-DTPA as a tool for evaluating the blood-brain barrier in post-stroke seizures. J Neurol 2012, 259:2041-2044.
58. Goerres G.W., Revesz T., Duncan J., Banati R.B. Imaging cerebral vasculitis in refractory epilepsy using [(11)C](R)-PK11195 positron emission tomography. AJR Am J Roentgenol 2001, 176:1016-1018.
59. Gulyas B., Pavlova E., Kasa P., Gulya K., Bakota L., Varszegi S., Keller E., Horvath M.C., Nag S., Hermecz I., Magyar K., Halldin C. Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Neurochem Int 2011, 58:60-68.
60. Haber R., Bessette D., Hulihan-Giblin B., Durcan M.J., Goldman D. Identification of tryptophan 2,3-dioxygenase RNA in rodent brain. J Neurochem 1993, 60:1159-1162.
61. Hammen T., Hildebrandt M., Stadlbauer A., Doelken M., Engelhorn T., Kerling F., Kasper B., Romstoeck J., Ganslandt O., Nimsky C., Blumcke I., Doerfler A., Stefan H. Non-invasive detection of hippocampal sclerosis: correlation between metabolite alterations detected by (1)H-MRS and neuropathology. NMR Biomed 2008, 21:545-552.
62. Harhausen D., Sudmann V., Khojasteh U., Muller J., Zille M., Graham K., Thiele A., Dyrks T., Dirnagl U., Wunder A. Specific imaging of inflammation with the 18kDa translocator protein ligand DPA-714 in animal models of epilepsy and stroke. PLoS ONE 2013, 8:e69529.
63. Hauser W.A., Rich S.S., Lee J.R., Annegers J.F., Anderson V.E. Risk of recurrent seizures after two unprovoked seizures. New Engl J Med 1998, 338:429-434.
64. Herholz K., Holzer T., Bauer B., Schroder R., Voges J., Ernestus R.I., Mendoza G., Weber-Luxenburger G., Lottgen J., Thiel A., Wienhard K., Heiss W.D. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 1998, 50:1316-1322.
65. Hirvonen J., Kreisl W.C., Fujita M., Dustin I., Khan O., Appel S., Zhang Y., Morse C., Pike V.W., Innis R.B., Theodore W.H. Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. J Nucl Med 2012, 53:234-240.
66. Hortala L., Arnaud J., Roux P., Oustric D., Boulu L., Oury-Donat F., Avenet P., Rooney T., Alagille D., Barret O., Tamagnan G., Barth F. Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor. Bioorg Med Chem Lett 2014, 24:283-287.
67. Hoyte L.C., Brooks K.J., Nagel S., Akhtar A., Chen R., Mardiguian S., McAteer M.A., Anthony D.C., Choudhury R.P., Buchan A.M., Sibson N.R. Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia. J Cereb Blood Flow Metab 2010, 30:1178-1187.
68. Iwamura H., Suzuki H., Ueda Y., Kaya T., Inaba T. In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. J Pharmacol Exp Ther 2001, 296:420-425.
69. Jacobs A.H., Tavitian B. Noninvasive molecular imaging of neuroinflammation. J Cereb Blood Flow Metab 2012, 32:1393-1415.
70. Jander S., Schroeter M., Saleh A. Imaging inflammation in acute brain ischemia. Stroke 2007, 38:642-645.
71. Jensen F.E. Epilepsy as a spectrum disorder: implications from novel clinical and basic neuroscience. Epilepsia 2011, 52(Suppl. 1):1-6.
72. Ji B., Maeda J., Sawada M., Ono M., Okauchi T., Inaji M., Zhang M.R., Suzuki K., Ando K., Staufenbiel M., Trojanowski J.Q., Lee V.M., Higuchi M., Suhara T. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J Neurosci 2008, 28:12255-12267.
73. Johnson E.W., de Lanerolle N.C., Kim J.H., Sundaresan S., Spencer D.D., Mattson R.H., Zoghbi S.S., Baldwin R.M., Hoffer P.B., Seibyl J.P., et al. "Central" and "peripheral" benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology 1992, 42:811-815.
74. Juhasz C., Buth A., Chugani D.C., Kupsky W.J., Chugani H.T., Shah A.K., Mittal S. Successful surgical treatment of an inflammatory lesion associated with new-onset refractory status epilepticus. Neurosurg Focus 2013, 34:E5.
75. Kanner A.M. Depression and the risk of neurological disorders. Lancet 2005, 366:1147-1148.
76. Kersemans K., Van Laeken N., De Vos F. Radiochemistry devoted to the production of monoamine oxidase (MAO-A and MAO-B) ligands for brain imaging with positron emission tomography. J Labelled Compd Radiopharm 2013, 56:78-88.
77. Khanolkar A.D., Lu D., Ibrahim M., Duclos R.I., Thakur G.A., Malan T.P., Porreca F., Veerappan V., Tian X., George C., Parrish D.A., Papahatjis D.P., Makriyannis A. Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity. J Med Chem 2007, 50:6493-6500.
78. Knight R.A., Karki K., Ewing J.R., Divine G.W., Fenstermacher J.D., Patlak C.S., Nagaraja T.N. Estimating blood and brain concentrations and blood-to-brain influx by magnetic resonance imaging with step-down infusion of Gd-DTPA in focal transient cerebral ischemia and confirmation by quantitative autoradiography with Gd-[(14)C]DTPA. J Cereb Blood Flow Metab 2009, 29:1048-1058.
79. Kreisl W.C., Fujita M., Fujimura Y., Kimura N., Jenko K.J., Kannan P., Hong J., Morse C.L., Zoghbi S.S., Gladding R.L., Jacobson S., Oh U., Pike V.W., Innis R.B. Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18kDa) in human and monkey: implications for positron emission tomographic imaging of this inflammation biomarker. NeuroImage 2010, 49:2924-2932.
80. Kumar A., Asano E., Chugani H.T. Alpha-[(1)(1)C]-methyl-l-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies. Biomarkers Med 2011, 5:577-584.
81. Kumar A., Chugani H.T., Luat A., Asano E., Sood S. Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. Pediatr Neurol 2008, 38:439-442.
82. Kumlien E., Bergstrom M., Lilja A., Andersson J., Szekeres V., Westerberg C.E., Westerberg G., Antoni G., Langstrom B. Positron emission tomography with [11C]deuterium-deprenyl in temporal lobe epilepsy. Epilepsia 1995, 36:712-721.
83. Kumlien E., Hilton-Brown P., Spannare B., Gillberg P.G. In vitro quantitative autoradiography of [3H]-l-deprenyl and [3H]-PK 11195 binding sites in human epileptic hippocampus. Epilepsia 1992, 33:610-617.
84. Kumlien E., Nilsson A., Hagberg G., Langstrom B., Bergstrom M. PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy. Acta Neurol Scand 2001, 103:360-366.
85. Kwan P., Brodie M.J. Early identification of refractory epilepsy. New Engl J Med 2000, 342:314-319.
86. Langen K.J., Muhlensiepen H., Holschbach M., Hautzel H., Jansen P., Coenen H.H. Transport mechanisms of 3-[123I]iodo-alpha-methyl-l-tyrosine in a human glioma cell line: comparison with [3H]methyl]-l-methionine. J Nucl Med 2000, 41:1250-1255.
87. Lavisse S., Guillermier M., Herard A.S., Petit F., Delahaye M., Van Camp N., Ben Haim L., Lebon V., Remy P., Dolle F., Delzescaux T., Bonvento G., Hantraye P., Escartin C. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci 2012, 32:10809-10818.
88. Le Fur G., Guilloux F., Rufat P., Benavides J., Uzan A., Renault C., Dubroeucq M.C., Gueremy C. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. Life Sci 1983, 32:1849-1856.
89. Le Fur G., Perrier M.L., Vaucher N., Imbault F., Flamier A., Benavides J., Uzan A., Renault C., Dubroeucq M.C., Gueremy C. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies. Life Sci 1983, 32:1839-1847.
90. Lemasters J.J., Theruvath T.P., Zhong Z., Nieminen A.L. Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta 2009, 1787:1395-1401.
91. Li L.M., Fish D.R., Sisodiya S.M., Shorvon S.D., Alsanjari N., Stevens J.M. High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit. J Neurol Neurosurg Psychiatry 1995, 59:384-387.
92. Liberatore M., Drudi F.M., Tarantino R., Prosperi D., Fiore V., Missori P., Venditti M., Delfini R. Tc-99m exametazime-labeled leukocyte scans in the study of infections in skull neurosurgery. Clin Nucl Med 2003, 28:971-974.
93. Librizzi L., Regondi M.C., Pastori C., Frigerio S., Frassoni C., de Curtis M. Expression of adhesion factors induced by epileptiform activity in the endothelium of the isolated guinea pig brain in vitro. Epilepsia 2007, 48:743-751.
94. Lopez-Villegas D., Lenkinski R.E., Wehrli S.L., Ho W.Z., Douglas S.D. Lactate production by human monocytes/macrophages determined by proton MR spectroscopy. Magn Reson Med 1995, 34:32-38.
95. Madakasira P.V., Simkins R., Narayanan T., Dunigan K., Poelstra R.J., Mantil J. Cortical dysplasia localized by [11C]methionine positron emission tomography: case report. AJNR Am J Neuroradiol 2002, 23:844-846.
96. Maeda Y., Oguni H., Saitou Y., Mutoh A., Imai K., Osawa M., Fukuyama Y., Hori T., Yamane F., Kubo O., Ishii K., Ishiwata K. Rasmussen syndrome: multifocal spread of inflammation suggested from MRI and PET findings. Epilepsia 2003, 44:1118-1121.
97. Majo V.J., Prabhakaran J., Simpson N.R., Van Heertum R.L., Mann J.J., Kumar J.S. A general method for the synthesis of aryl [11C]methylsulfones: potential PET probes for imaging cyclooxygenase-2 expression. Bioorg Med Chem Lett 2005, 15:4268-4271.
98. Marchi N., Granata T., Ghosh C., Janigro D. Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches. Epilepsia 2012, 53:1877-1886.
99. Maroso M., Balosso S., Ravizza T., Iori V., Wright C.I., French J., Vezzani A. Interleukin-1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 2011, 8:304-315.
100. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., Rossetti C., Molteni M., Casalgrandi M., Manfredi A.A., Bianchi M.E., Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010, 16:413-419.
101. McAteer M.A., Sibson N.R., von Zur Muhlen C., Schneider J.E., Lowe A.S., Warrick N., Channon K.M., Anthony D.C., Choudhury R.P. In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat Med 2007, 13:1253-1258.
102. McCarthy T.J., Sheriff A.U., Graneto M.J., Talley J.J., Welch M.J. Radiosynthesis, in vitro validation, and in vivo evaluation of 18F-labeled COX-1 and COX-2 inhibitors. J Nucl Med 2002, 43:117-124.
103. Mihaly A., Bozoky B. Immunohistochemical localization of extravasated serum albumin in the hippocampus of human subjects with partial and generalized epilepsies and epileptiform convulsions. Acta Neuropathol 1984, 65:25-34.
104. Miron V.E., Boyd A., Zhao J.W., Yuen T.J., Ruckh J.M., Shadrach J.L., van Wijngaarden P., Wagers A.J., Williams A., Franklin R.J., ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 2013, 16:1211-1218.
105. Mizuno S., Takahashi Y., Kato Z., Goto H., Kondo N., Hoshi H. Magnetic resonance spectroscopy of tubers in patients with tuberous sclerosis. Acta Neurol Scand 2000, 102:175-178.
106. Mu L., Bieri D., Slavik R., Drandarov K., Muller A., Cermak S., Weber M., Schibli R., Kramer S.D., Ametamey S.M. Radiolabeling and in vitro /in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor. J Neurochem 2013, 126:616-624.
107. Mueller S.G., Laxer K.D., Suhy J., Lopez R.C., Flenniken D.L., Weiner M.W. Spectroscopic metabolic abnormalities in mTLE with and without MRI evidence for mesial temporal sclerosis using hippocampal short-TE MRSI. Epilepsia 2003, 44:977-980.
108. Murphy J.M., Balan K.K., Toms A., Gomez-Anson B., Lockwood M. Radiolabeled leucocyte imaging in diffuse granulomatous involvement of the meninges in Wegener's granulomatosis: scintigraphic findings and their role in monitoring treatment response to specific immunotherapy (humanized monoclonal antilymphocyte antibodies). AJNR Am J Neuroradiol 2000, 21:1460-1465.
109. Nag S., Lehmann L., Kettschau G., Heinrich T., Thiele A., Varrone A., Gulyas B., Halldin C. Synthesis and evaluation of [(1)(8)F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B). Bioorg Med Chem 2012, 20:3065-3071.
110. Nag S., Lehmann L., Kettschau G., Toth M., Heinrich T., Thiele A., Varrone A., Halldin C. Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B). Bioorg Med Chem 2013, 21:6634-6641.
111. Nagaraja T.N., Nagesh V., Ewing J.R., Whitton P.A., Fenstermacher J.D., Knight R.A. Step-down infusions of Gd-DTPA yield greater contrast-enhanced magnetic resonance images of BBB damage in acute stroke than bolus injections. Magn Reson Imaging 2007, 25:311-318.
112. Nighoghossian N., Wiart M., Cakmak S., Berthezene Y., Derex L., Cho T.H., Nemoz C., Chapuis F., Tisserand G.L., Pialat J.B., Trouillas P., Froment J.C., Hermier M. Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients. Stroke 2007, 38:303-307.
113. Obenaus A. Neuroimaging biomarkers for epilepsy: advances and relevance to glial cells. Neurochem Int 2013, 63:712-718.
114. Oude Engberink R.D., Blezer E.L., Hoff E.I., van der Pol S.M., van der Toorn A., Dijkhuizen R.M., de Vries H.E. MRI of monocyte infiltration in an animal model of neuroinflammation using SPIO-labeled monocytes or free USPIO. J Cereb Blood Flow Metab 2008, 28:841-851.
115. Owen D.R., Gunn R.N., Rabiner E.A., Bennacef I., Fujita M., Kreisl W.C., Innis R.B., Pike V.W., Reynolds R., Matthews P.M., Parker C.A. Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J Nucl Med 2011, 52:24-32.
116. Owen D.R., Yeo A.J., Gunn R.N., Song K., Wadsworth G., Lewis A., Rhodes C., Pulford D.J., Bennacef I., Parker C.A., StJean P.L., Cardon L.R., Mooser V.E., Matthews P.M., Rabiner E.A., Rubio J.P. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab 2012, 32:1-5.
117. Papadopoulos V., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapere J.J., Lindemann P., Norenberg M.D., Nutt D., Weizman A., Zhang M.R., Gavish M. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006, 27:402-409.
118. Petit-Taboue M.C., Baron J.C., Barre L., Travere J.M., Speckel D., Camsonne R., MacKenzie E.T. Brain kinetics and specific binding of [11C]PK 11195 to omega 3 sites in baboons: positron emission tomography study. Eur J Pharmacol 1991, 200:347-351.
119. Pomper M.G., Musachio J.L., Scheffel U., Macdonald J.E., McCarthy D.J., Reif D.W., Villemagne V.L., Yokoi F., Dannals R.F., Wong D.F. Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studies. J Nucl Med 2000, 41:1417-1425.
120. Prabhakaran J., Underwood M.D., Parsey R.V., Arango V., Majo V.J., Simpson N.R., Van Heertum R., Mann J.J., Kumar J.S. Synthesis and in vivo evaluation of [18F]-4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamid e as a PET imaging probe for COX-2 expression. Bioorg Med Chem 2007, 15:1802-1807.
121. Raps S.P., Lai J.C., Hertz L., Cooper A.J. Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res 1989, 493:398-401.
122. Ravizza T., Balosso S., Vezzani A. Inflammation and prevention of epileptogenesis. Neurosci Lett 2011, 497:223-230.
123. Regesta G., Tanganelli P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res 1999, 34:109-122.
124. Rhee M.H., Vogel Z., Barg J., Bayewitch M., Levy R., Hanus L., Breuer A., Mechoulam R. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase. J Med Chem 1997, 40:3228-3233.
125. Riederer F., Bittsansky M., Schmidt C., Mlynarik V., Baumgartner C., Moser E., Serles W. 1H magnetic resonance spectroscopy at 3T in cryptogenic and mesial temporal lobe epilepsy. NMR Biomed 2006, 19:544-553.
126. Riss P.J., Hong Y.T., Marton J., Caprioli D., Williamson D.J., Ferrari V., Saigal N., Roth B.L., Henriksen G., Fryer T.D., Dalley J.W., Aigbirhio F.I. Synthesis and evaluation of 18F-FE-PEO in rodents: an 18F-labeled full agonist for opioid receptor imaging. J Nucl Med 2013, 54:299-305.
127. Roch C., Leroy C., Nehlig A., Namer I.J. Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia 2002, 43:325-335.
128. Rossin R., Muro S., Welch M.J., Muzykantov V.R., Schuster D.P. In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium. J Nucl Med 2008, 49:103-111.
129. Rupprecht R., Papadopoulos V., Rammes G., Baghai T.C., Fan J., Akula N., Groyer G., Adams D., Schumacher M. Translocator protein (18kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 2010, 9:971-988.
130. Sagredo O., Gonzalez S., Aroyo I., Pazos M.R., Benito C., Lastres-Becker I., Romero J.P., Tolon R.M., Mechoulam R., Brouillet E., Romero J., Fernandez-Ruiz J. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. Glia 2009, 57:1154-1167.
131. Santillo A.F., Gambini J.P., Lannfelt L., Langstrom B., Ulla-Marja L., Kilander L., Engler H. In vivo imaging of astrocytosis in Alzheimer's disease: an (1)(1)C-l-deuteriodeprenyl and PIB PET study. Eur J Nucl Med Mol Imaging 2011, 38:2202-2208.
132. Sasaki M., Kuwabara Y., Yoshida T., Fukumura T., Morioka T., Nishio S., Fukui M., Masuda K. Carbon-11-methionine PET in focal cortical dysplasia: a comparison with fluorine-18-FDG PET and technetium-99m-ECD SPECT. J Nucl Med 1998, 39:974-977.
133. Saura J., Luque J.M., Cesura A.M., Da Prada M., Chan-Palay V., Huber G., Loffler J., Richards J.G. Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 1994, 62:15-30.
134. Sauvageau A., Desjardins P., Lozeva V., Rose C., Hazell A.S., Bouthillier A., Butterwort R.F. Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis. Metab Brain Dis 2002, 17:3-11.
135. Scarf A.M., Kassiou M. The translocator protein. J Nucl Med 2011, 52:677-680.
136. Schoonenboom N.S., van der Flier W.M., Blankenstein M.A., Bouwman F.H., Van Kamp G.J., Barkhof F., Scheltens P. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease. Neurobiol Aging 2008, 29:669-675.
137. Schweitzer P.J., Fallon B.A., Mann J.J., Kumar J.S. PET tracers for the peripheral benzodiazepine receptor and uses thereof. Drug Discov Today 2010, 15:933-942.
138. Shaffer J.L., Petrella J.R., Sheldon F.C., Choudhury K.R., Calhoun V.D., Coleman R.E., Doraiswamy P.M. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 2013, 266:583-591.
139. Shah F., Hume S.P., Pike V.W., Ashworth S., McDermott J. Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl Med Biol 1994, 21:573-581.
140. Shao X., Zhang H., Rajian J.R., Chamberland D.L., Sherman P.S., Quesada C.A., Koch A.E., Kotov N.A., Wang X. 125I-labeled gold nanorods for targeted imaging of inflammation. ACS Nano 2011, 5:8967-8973.
141. Shultz S.R., O'Brien T.J., Stefanidou M., Kuzniecky R.I. Neuroimaging the epileptogenic process. Neurotherapeutics 2014, 11:347-357.
142. Simister R.J., Woermann F.G., McLean M.A., Bartlett P.A., Barker G.J., Duncan J.S. A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy. Epilepsia 2002, 43:1021-1031.
143. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009, 32:638-647.
144. Spinelli F., Sara R., Milella M., Ruffini L., Sterzi R., Causarano I.R., Sberna M. Technetium-99m hexamethylpropylene amine oxime leucocyte scintigraphy in the differential diagnosis of cerebral abscesses. Eur J Nucl Med 2000, 27:46-49.
145. Stefansson S.B., Olafsson E., Hauser W.A. Psychiatric morbidity in epilepsy: a case controlled study of adults receiving disability benefits. J Neurol Neurosurg Psychiatry 1998, 64:238-241.
146. Stober B., Tanase U., Herz M., Seidl C., Schwaiger M., Senekowitsch-Schmidtke R. Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-l-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging 2006, 33:932-939.
147. Stoll G., Bendszus M. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Neuroscience 2009, 158:1151-1160.
148. Takano T., Kang J., Jaiswal J.K., Simon S.M., Lin J.H., Yu Y., Li Y., Yang J., Dienel G., Zielke H.R., Nedergaard M. Receptor-mediated glutamate release from volume sensitive channels in astrocytes. Proc Natl Acad Sci USA 2005, 102:16466-16471.
149. Taylor M.W., Feng G.S. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 1991, 5:2516-2522.
150. Tellez-Zenteno J.F., Hernandez Ronquillo L., Moien-Afshari F., Wiebe S. Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res 2010, 89:310-318.
151. Thurman D.J., Beghi E., Begley C.E., Berg A.T., Buchhalter J.R., Ding D., Hesdorffer D.C., Hauser W.A., Kazis L., Kobau R., Kroner B., Labiner D., Liow K., Logroscino G., Medina M.T., Newton C.R., Parko K., Paschal A., Preux P.M., Sander J.W., Selassie A., Theodore W., Tomson T., Wiebe S. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 2011, 52(suppl. 7):2-26.
152. Tolon R.M., Nunez E., Pazos M.R., Benito C., Castillo A.I., Martinez-Orgado J.A., Romero J. The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages. Brain Res 2009, 1283:148-154.
153. Turkdogan-Sozuer D., Ozek M.M., Sav A., Dincer A., Pamir M.N. Serial MRI and MRS studies with unusual findings in Rasmussen's encephalitis. Eur Radiol 2000, 10:962-966.
154. Turkman N., Shavrin A., Paolillo V., Yeh H.H., Flores L., Soghomonian S., Rabinovich B., Volgin A., Gelovani J., Alauddin M. Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor. Nucl Med Bio 2012, 39:593-600.
155. Van Camp N., Boisgard R., Kuhnast B., Theze B., Viel T., Gregoire M.C., Chauveau F., Boutin H., Katsifis A., Dolle F., Tavitian B. In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [(11)C]CLINME and [(11)C]PK11195 in an acute rodent model. Eur J Nucl Med Mol Imaging 2010, 37:962-972.
156. van Vliet E.A., da Costa Araujo S., Redeker S., van Schaik R., Aronica E., Gorter J.A. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534.
157. van Vliet E.A., Otte W.M., Gorter J.A., Dijkhuizen R.M., Wadman W.J. Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study. Neurobiol Dis 2014, 63:74-84.
158. Varella P.P., Santiago J.F., Carrete H., Higa E.M., Yacubian E.M., Centeno R.S., Caboclo L.O., Castro Neto E.F., Canzian M., Amado D., Cavalheiro E.A., Naffah-Mazzacoratti Mda G. Relationship between fluid-attenuated inversion-recovery (FLAIR) signal intensity and inflammatory mediator's levels in the hippocampus of patients with temporal lobe epilepsy and mesial temporal sclerosis. Arq Neuropsiquiatr 2011, 69:91-99.
159. Venneti S., Lopresti B.J., Wiley C.A. The peripheral benzodiazepine receptor (translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol 2006, 80:308-322.
160. Verbist B.M., De Cleyn M.A., Surkyn M., Fraiponts E., Aerssens J., Nijsen M.J., Gijsen H.J. 5-Sulfonyl-benzimidazoles as selective CB2 agonists. Bioorg Med Chem Lett 2008, 18:2574-2579.
161. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat Rev Neurol 2011, 7:31-40.
162. Vezzani A., Granata T. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005, 46:1724-1743.
163. Vezzani A., Ruegg S. The pivotal role of immunity and inflammatory processes in epilepsy is increasingly recognized: introduction. Epilepsia 2011, 52(suppl. 3):1-4.
164. Wadsworth H., Jones P.A., Chau W.F., Durrant C., Fouladi N., Passmore J., O'Shea D., Wynn D., Morisson-Iveson V., Ewan A., Thaning M., Mantzilas D., Gausemel I., Khan I., Black A., Avory M., Trigg W. [(1)(8)F]GE-180: a novel fluorine-18 labelled PET tracer for imaging translocator protein 18kDa (TSPO). Bioorg Med Chem Lett 2012, 22:1308-1313.
165. Weinstein J.S., Varallyay C.G., Dosa E., Gahramanov S., Hamilton B., Rooney W.D., Muldoon L.L., Neuwelt E.A. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 2010, 30:15-35.
166. Wiebe S., Blume W.T., Girvin J.P., Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. New Engl J Med 2001, 345:311-318.
167. Wunder A., Klohs J., Dirnagl U. Non-invasive visualization of CNS inflammation with nuclear and optical imaging. Neuroscience 2009, 158:1161-1173.
168. Wust F.R., Hohne A., Metz P. Synthesis of 18F-labelled cyclooxygenase-2 (COX-2) inhibitors via Stille reaction with 4-[18F]fluoroiodobenzene as radiotracers for positron emission tomography (PET). Org Biomol Chem 2005, 3:503-507.
169. Yamazaki F., Kuroiwa T., Takikawa O., Kido R. Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem J 1985, 230:635-638.
170. Zhang J., McCarthy T.J., Moore W.M., Currie M.G., Welch M.J. Synthesis and evaluation of two positron-labeled nitric oxide synthase inhibitors, S-[11C]methylisothiourea and S-(2-[18F]fluoroethyl)isothiourea, as potential positron emission tomography tracers. J Med Chem 1996, 39:5110-5118.
171. Zhang J., Xu M., Dence C.S., Sherman E.L., McCarthy T.J., Welch M.J. Synthesis, in vivo evaluation and PET study of a carbon-11-labeled neuronal nitric oxide synthase (nNOS) inhibitor S-methyl-l-thiocitrulline. J Nucl Med 1997, 38:1273-1278.
172. Zhang Y., Londos E., Minthon L., Wattmo C., Liu H., Aspelin P., Wahlund L.O. Usefulness of computed tomography linear measurements in diagnosing Alzheimer's disease. Acta Radiol 2008, 49:91-97.
173. Zunszain P.A., Anacker C., Cattaneo A., Choudhury S., Musaelyan K., Myint A.M., Thuret S., Price J., Pariante C.M. Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 2012, 37:939-949.
174. Zurolo E., Iyer A.M., Spliet W.G., Van Rijen P.C., Troost D., Gorter J.A., Aronica E. CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies. Neuroscience 2010, 170:28-41.